Category:

Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large B-cell lymphoma at the EHA 2021 Virtual Congress – Business Wire

CONTEXT:  Presentation at the European Hematology Association (EHA) 2021 Virtual Congress of a post-approval safety study on Truxima (biosimiliar rituximab) in patients with large B-cell lymphoma.  Results showed similar results Continue Reading

Posted On : Published By : Ken Ashman
Category:

Real-World Outcomes of Febrile Neutropenia Among Patients With Breast Cancer or Non-Hodgkin Lymphoma – Journal of Clinical Pathways

CONTEXT:  Transcript of a poster presentation made at the National Comprehensive Cancer Network (NCCN) Annual Conference 2021 on real-world outcomes of febrile neutropenia among patients with breast cancer or non-hodgkin Continue Reading

Posted On : Published By : Ken Ashman